EUCTR2020-000120-19-BE招募中1 期
Activity and safety of peptide-based immunotherapy in an umbrella window pre-operative opportunity phase II study in patients with squamous cell carcinoma of the head and neck. - HN1901
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •Squamous cell carcinome of hypopharynx, larynx, orolarynx, oral cavity
- •Elective for curative treatment
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 30
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 30
排除标准
- •Distant metastases
- •Squamous cell carcinoma of nasal and sinusal cavities, nasopharynx and unknown primary
研究者
相似试验
终止
2 期
Activity and Safety of Peptide-based Immunotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck.Oropharynx Squamous Cell CarcinomaLarynx Squamous Cell CarcinomaHypopharynx Squamous Cell CarcinomaOral Cavity Squamous Cell CarcinomaNCT04445064Cliniques universitaires Saint-Luc- Université Catholique de Louvain17
招募中
1 期
Peptides pulsed dendritic cell vaccine for hepatocellular carcinomaHepatocellular carcinomaLiver cancerJPRN-jRCTc040190093Mizukoshi Eishiro6
已完成
1 期
Vaccine Therapy in Treating Patients With Ovarian Epithelial or Primary Peritoneal CancerPrimary Peritoneal Cavity CancerOvarian CancerNCT00091273University of Virginia9
已完成
1 期
Vaccine Therapy, Incomplete Freund's Adjuvant, and GM-CSF in Treating Patients With HIVNonneoplastic ConditionNCT00381875National Institutes of Health Clinical Center (CC)40
已完成
1 期
Peptide Vaccine Targeting to Cancer Specific Antigen Combined With Anti-angiogenic Peptide Antigen in Treating Patients With Non-small Cell Lung CancerNon Small Cell Lung CancerNCT00874588Fukushima Medical University6